The MAPK activity drives the uncontrolled growth of melanoma cells by upregulating the expression of cyclin D1 and through the suppression of the cyclin-dependent kinase inhibitor p27KIP1 (Smalley, 2003; Bhatt et al, 2005). Here, CDKN1B is linked to melanoma.